A Phase II, Single Arm, Open Label, Multi-center Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT05787639

Study Contact: studies@hoosiercancer.org; (317) 921-2050.